508.907.6424 | npace@npace.org | | Blog
Loading Events

Chicago, IL

April 4 - 7, 2020


In light of the recent COVID-19 developments and the increased demand for nurse practitioners to remain in place for patient care, NPACE has made the difficult but necessary decision to cancel the NPACE Primary Care & Pharmacology Conference in Chicago (April 4-7). We are actively working on providing a virtual educational offering for our Chicago attendees to provide them with the credit hours they need. Chicago registrants will receive additional details related to refunds and virtual learning options in the coming days.

Chicago, IL Conference
2-day Primary Care + 2-day Pharmacology
April 4-7, 2020
Chicago Marriott Downtown Magnificent Mile



Fulfill your professional development and specific licensure needs at these 2-day Primary Care and 2-day Pharmacotherapeutics NP continuing education conferences. Chicago, IL Conference sessions emphasize the latest evidence and guideline-based clinical knowledge needed to prescribe and manage high priority primary care topics.

Primary Care (April 4-5) | 10 Contact Hours/(TBA Pharm Hours)
Pharmacology (April 6-7) | 12 Contact Hours/12 Pharm Hours

Conference Registration Deadlines/Fees

Early Registration – by March 2, 2020
General Attendee: $355 (one conference) | $680 (both conferences)
Senior (60+), Student/New Grad: $315 (one conference) | $635 (both conferences)

Standard Registration (all types except Military)  – after March 2, 2020
$420 (one conference) | $800 (both conferences)

Military – (anytime)
$295 (one conference) | $585 (both conferences)

All registrations are subject to a $50 non-refundable administration fee.

Keynote speaker


See all NPACE events


Keynote Speaker: Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Wendy received her Doctor of Nursing Practice in 2019 from the University of Alabama, Tuscaloosa. She is a 1992 graduate of the Adult Primary Care Nurse Practitioner program at Simmons College in Boston, Massachusetts and completed a family nurse practitioner post-master’s program in 1995. She is an adult and family nurse practitioner and the owner of two, nurse practitioner owned and operated clinics within New Hampshire named: Wright & Associates Family Healthcare. Her family practices have won numerous awards, including Top Providers in New Hampshire 2018, Top 20 Fastest Growing Family Business, and Top 20 Women-Owned Business in New Hampshire. In addition, she is the Owner of Partners in Healthcare Education, a medical education company. She is the Past President of NPACE and the Senior lecturer for Fitzgerald Health Education Associates. She is the recipient of numerous awards and was chosen by the American Association of Nurse Practitioners as the 1999 recipient of the New Hampshire State Excellence Award. In addition, she received the 2009 NH Nurse Practitioner of the Year and the 2014 Top 5 Women in New Hampshire Business Award. In 2005, she was inducted as a Fellow into the American Academy of Nurse Practitioners; in October 2014, a Fellow in the American Academy of Nursing, and in March 2017, a Fellow into the National Academies of Practice. She is the founder of the NH Chamber of Entrepreneurial Nurse Practitioners, an organization designed to assist nurse practitioners with independent practice issues. In addition to full-time clinical practice, she presents nationally to different audiences and has been a speaker at over 1000 conferences in 47 states. She is the nurse practitioner representative to the State of NH Immunization Advisory Board. She has been a medical media spokesperson for numerous companies and has appeared on radio, television, and in print magazines. Wendy is frequently consulted by malpractice attorneys around the area of clinical practice and has worked on more than 100 malpractice cases involving nurses and nurse practitioners.
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
Nancy R. Berman has been in practice as an Adult Nurse Practitioner with emphasis in women’s health care since 1978. She received her Bachelor of Science in Nursing from the University of Michigan and her Master of Science in Nursing from Wayne State University in Detroit, Michigan. Currently, she specializes in women’s health care at Millennium Affiliated Physicians, a division of Michigan Healthcare Professionals, in Farmington Hills, Michigan. She is a clinical instructor in the Department of Obstetrics and Gynecology at Wayne State University School of Medicine in Detroit, Michigan. She holds the certification of Menopause Practitioner from the North American Menopause Society. She is a fellow of the American Association of Nurse Practitioners. Ms. Berman has taught extensively on lower genital tract disease, including HPV, cervical cancer prevention, HPV testing and HPV vaccine, management of the abnormal Pap test, colposcopy and vulvar and vaginal disease. She has also been active in education in the management of menopause and osteoporosis. She served on the Board of Directors of the American Society for Colposcopy and Cervical Pathology (ASCCP) from 2009 to 2016, co-chaired their education committee, and holds their Colposcopy Recognition Award. She serves on the Michigan Cervical Cancer Consortium and served on the Michigan Governor’s Task Force on Cervical Cancer. Recent publications by Ms. Berman have appeared in The Journal for Nurse Practitioners, ADVANCE for Nurse Practitioners, Women’s Health in Primary Care, and chapters in Advanced Health Assessment of Women 4th edition and the Atlas of Primary Care Procedures, 3rd edition, Lippincott, Williams.
Lynn Chilton, DSN, FNP-BC, GNP-BC
Lynn Chilton is certified as a GNP and an FNP and has practiced as an NP in several clinics. She is currently a Professor in the MSN and DNP Adult-Geron Nurse Practitioner Program at the University of South Alabama.
Jason Cross, PharmD, BCPS, BCACP
Doctor of Pharmacy in 2001: University of Rhode Island Associate Professor of Pharmacy, MCPHS-University Clinical Specialist- Baystate Medical Center Board Certified in Pharmacotherapy and Am Care
Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP
Dr. Kathleen Haycraft is a nurse practitioner certified in family, pediatrics, and dermatology. She is working at Riverside Dermatology in general dermatology in Hannibal, Missouri. Kathleen received her doctorate from University of Kansas City Missouri where she was recognized in 2014 as their alumni of the year. Dr. Haycraft is active in the American Association of Nurse Practitioners where she was recognized as their first clinical excellence award winner in Missouri and served as Missouri representative for five years. Kathleen has a passion for dermatology and lectures and writes on dermatology issues. She serves with other dermatology experts on the planning committee for Maui Dermatology. Her other passion is health care policy where she has served as chair for the Advance Practice Nursing Coalition of Missouri and the Action Coalition for Advance Practice Nurses, and has been honored by both Gubernatorial (education) and Speaker (Medicaid Transformation) committees.
Christine Kessler, MN, CNS, ANP-C, BC-ADM, CDTC, FAANP
Christine Kessler is an award-winning nurse practitioner, national/international speaker, prolific author, and clinical consultant specializing in Endocrinology and Metabolic Medicine. During her 45 years of nursing (38 years in advanced practice) she has held diverse roles in management, research, academia, and clinical practice; the latter as a critical care clinical specialist, an acute care nurse practitioner (as an Intensivist) and an adult nurse practitioner. After 15 years as the senior nurse practitioner at the Walter Reed National Military Medical Center, Department of Endocrinology and Metabolic Medicine, Christine now focuses on providing diabetes and weight loss management, as well as general endocrine clinical and home services to an under-served population in rural Virginia. Christine has received many clinical practice awards, among them the Silver Ace Top Clinician award (voted by her medical peers), several Army Achievement awards, the prestigious Outstanding Civilian Service Award, and the Coin of Excellent personally awarded by the Surgeon General for having the highest patient satisfaction rating of all health care providers in the Army WORLDWIDE. Christine co-chairs the popular, national Metabolic & Endocrine Disease Summit and is a Fellow of the American Association of Nurse Practitioners.
Nancy Nadolski, MSN, M.Ed, FNP-C
Nancy Nadolski, Family Nurse Practitioner, received her BSN from Washington State University followed by a Master’s degree in Counseling from the College of Idaho and then a Masters in Nursing, from Gonzaga University, which allowed her to become certified as a nurse practitioner and to begin prescribing for her patients. Nancy has spent 18 years practicing in Psychiatric and Insomnia Medicine in private practice in Boise, Idaho. Together with her coworkers, they published articles for professional publications and co-authored a book for the mental health practitioner called 40 Cases: Understanding Psychiatric Medications. Nancy speaks at national and international primary care, psychiatric and counseling conferences. She presented at the International Nurse Practitioner Conference in the Netherlands and has presented in every state except Arkansas. Nancy recently became certified as a Certified Daring Way Facilitator. The Daring Way is grounded in research by Brene’ Brown and looks shame and guilt squarely in the face as the barriers to Whole Hearted Living.
Brett Snodgrass, FNP-C, CPE, FACPP, FAANP
Brett Badgley Snodgrass has been a Family Nurse Practitioner for 12 years, practicing in multiple settings. She is the NP Director of Palliative Care Services for the Baptist Healthcare System in Memphis, TN. She is also the owner of BBS Health Education – where she creates and presents continuing education for healthcare providers, both live and online. She is a nationally recognized nurse practitioner speaker and teacher. She is also an award-winning healthcare blogger – The NP Mom. Her blog offers answers to patient’s questions they often forget to ask! You can visit her blog at www.thenpmom.wordpress.com. Brett Is a chronic pain expert, working for more than 20 years with chronic pain patients in many settings. Brett is board certified with the American Association of Nurse Practitioners, where she is currently the TN State Representative. She is also a Fellow of the American Association of Nurse Practitioners. Brett received the 2015 AANP State Excellence Award for Tennessee for her work across the state on the TN Chronic Pain Task Force, as well as advocating for TN Full Practice Authority for Nurse Practitioners. She was also awarded the 2017 Memphis Business Journal Healthcare Hero Award.


Saturday, April 4, 2020


7:00 am - 8:00 am
Primary Care Conference Registration

Primary Care Conference

8:00 am - 9:00 am
Keynote: Staying Involved Is More Important Than Ever Before: The Impact of Policy and Politics
9:15 am - 10:15 am
PCEC1: IBS: Easing the Patient Burden

Family care clinicians are the first line of defense for patients suffering from IBS, a common disorder that causes substantial reduction in health-related quality of life. The diagnosis of IBS, whether it is IBS-D, IBS-M, or IBS-C, is generally made clinically, which is impacted by recent changes in the Rome criteria. Now recognized as both a brain-gut and a gut-brain disorder, the treatment of patients with IBS has evolved significantly in the past year. Understanding the patient burden of disease, particularly symptoms that are most troublesome, is helpful in individualizing therapy. The 2018 American College of Gastroenterology IBS guidelines lend clarity to treatments found effective, including soluble fiber and several medications, while finding little evidence to support the use of therapies such as a gluten-free diet, prebiotics/probiotics/synbiotics, and antispasmodics.

Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. 

Grant funded by Salix Pharmaceuticals, Inc.

10:25 am - 11:25 am
A1: Palliative Care

Palliative medicine is a relatively new specialty. It is important that advance care planning take place before a patient faces s serious illness or medical emergency. Primary care is the best place for these conversations, due to the relationship of a patient and their primary care provider. This section will explained advance care planning and how to have the sometimes difficult conversation.

11:25 am - 12:00 pm
Sign in with Sponsor for Product Theater
12:00 pm - 1:00 pm
LP1: NON-CE Product Theater Lunch Session

This session is provided by a commercial interest. Contact Hours will not be awarded.

1:15 pm - 2:15 pm
PCEC2: Diabetes Management: Putting the Patient First

The management of patients with T2DM has undergone a seismic shift from a glucose- centric to a patient-centric focus with a primary goal of reducing cardiovascular risk. The shift to focus on cardiovascular risk stems not only from the fact that microvascular and macrovascular complications continue to be common in persons with type 2 diabetes mellitus, but also from evolving evidence clearly demonstrating cardiovascular risk reduction with some antidiabetic medications. To reduce the burden of disease and improve the journey of persons with type 2 diabetes, however, requires understanding the evidence base for these benefits and differences among the antidiabetic medications, and how treatment can be individualized to address the unmet needs of each patient.

Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits.

Grant funded by Lilly.

2:30 pm - 3:30 pm
B1: Diagnosing and Treating Lumbar Spine Disorders

Low back pain is a common complaint in primary care. It is important to recognize red flags associated with low back pain, as well as evidenced based guidelines for appropriate management in primary care.

4:00 pm - 7:00 pm
Psoriasis Dinner Program

In conjunction with the National Psoriasis Foundation this Psoriasis Recognition Program is designed to help enhance your skills in caring for those with psoriasis. After completing this program, attendees will be formally recognized as up-to-date in the latest psoriasis education.

This activity is supported by educational grants from Bristol-Myers Squibb and Janssen.

The National Psoriasis Foundation designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM

Click to Register for this Program

Sunday, April 5, 2020

Primary Care Conference

7:00 am - 8:00 am
BR1: Stemming the Progression of Diabetic Kidney Disease: The Role of the Primary Care Clinician

The pharmacologic treatment of diabetic kidney disease (DKD) has typically involved treatment of associated risk factors such as blood glucose, blood pressure, and the use of medications that act on the renin-angiotensin-aldosterone system. Recently, a variety of glucose-lowering medications have been investigated to assess their potential for improved renal outcomes in patients with type 2 diabetes mellitus and with/without established DKD. Several of these medications have been shown to improve renal outcomes in patients with type 2 diabetes mellitus. This presentation seeks to provide insight into the results of these clinical trials and how the selected medications can be used to individualize therapy as recommended in updated guidelines issued by the American Diabetes Association and the American Association of Clinical Endocrinologists/ American College of Endocrinology.

*Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a separate certificate of participation for this activity. ANCC accepts AAFP Prescribed credit and AMA PRA Category 1 Credits. Sponsored by PCEC and PCMG. Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc

8:15 am - 9:15 am
C1: HPV and Cervical Cancer Prevention

This session will review the natural history of HPV, current screening guidelines for cervical cancer prevention and appropriate uses of HPV testing. There will be a discussion of HPV testing in the triage of the borderline abnormal Pap test, co-testing with Pap and HPV and an introduction to HPV primary stand-alone testing. There will be an overview of the role of HPV in anal cancer, screening with anal cytology and high resolution anoscopy as well as a look at the role of HPV in oropharyngeal cancer. There will also be a look at the next generation of risk-based management which is coming in the near future.

9:15 am - 9:45 am
Exhibit Hall Grand Opening
9:45 am - 10:45 am
D1: Identifying Skin Cancer and Knowing What to Do Next

At the conclusion of this session attendees will be able to identify actinic keratosis and squamous cell cancer and determine an appropriate treatment plan, identify basal cell cancer and determine an appropriate treatment plan and identify dysplastic nevi and malignant melanoma and determine an appropriate treatment plan.

10:55 am - 11:55 am
E1: The Latest in Treating Hypertension

2017 AHA Guidelines have tweaked the treatment of hypertension once again. What are the latest guidelines? How can you put them to work for your patients?

11:55 am - 12:30 pm
Sign in with Sponsor for Product Theater
12:30 pm - 1:30 pm
LP2: NON-CE Product Theater Lunch Session

This session is provided by a commercial interest. Contact Hours will not be awarded.

1:45 pm - 2:45 pm
F1: Vulvar and Vaginal Disease

This session will present an overview of normal vulvar and vaginal anatomy, when and where to biopsy, and the clinical appearance and management of HPV disease including condyloma and low and high grade neoplastic disease. The session will then review common vulvar and vaginal benign disease presentations and management including lichen sclerosus, lichen simplex chronicus, lichen planus, psoriasis, and atopic dermatitis. A gallery of clinical photos will be presented along with recommendations for treatment.

3:15 pm - 4:15 pm
G1: Common Dermatologic Conditions and How to Manage Them

This session will allow participants to be able to identify: Acne, Atopic Dermatitis, Warts, Tinea, Pruritis (and associated lesions) as well as treatment plans. This session will also engage learners in high level assessment and associated treatment for acne, atopic dermatitis, warts, tinea and pruritis.

Monday, April 6, 2020


7:00 am - 8:00 am
Pharmacology Conference Registration

Pharmacology Conference

8:00 am - 9:30 am
PH1: Genomic Medicine and Pharmacogenetics: What Clinicians Should Absolutely Know

The emergence of genomics and precision medicine is sure to bring about seismic changes in healthcare delivery. Using case studies, this intriguing session will critically examine the expanding field of genomic medicine (including pharmacogenomics and use of biomarkers) and demonstrate how it’s integration into clinical practice may help to more precisely evaluate, diagnose, manage and prevent selected acute and chronic medical conditions.

10:00 am - 11:30 am
PH2: Pharmacotherapy of Chronic and Acute Thyroid Disorders

Using case studies, this session will provide endocrinology expert tips on how to detect, diagnose and treat the second most common endocrine disorder…thyroid disease. The focus will be on how to manipulate various thyroid hormone replacement drugs, as well as antithyroid medications in clinical and urgent situations.

11:30 am - 12:00 pm
Sign in with Sponsor for Product Theater
12:00 pm - 1:00 pm
PH-LP1: NON-CE Product Theater Lunch Session

This session is provided by a commercial interest. Contact Hours will not be awarded.

1:15 pm - 2:45 pm

COPD is a common preventable and treatable disease which is characterized by persistent airflow limitation. COPD is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases (90% of cases is due to smoking). Exacerbations and comorbidities contribute to the overall severity in individual patients. COPD management is driven by the yearly update of the GOLD Executive Summary (Global Initiative for Chronic Obstructive Lung Disease). Evidence based goal directed therapy is paramount in COPD management to slow the progression of COPD and improve patient quality of life.

2:55 pm - 4:25 pm
PH4: Heart Failure Management Updates

Heart failure is when the heart is unable to pump sufficiently to maintain blood flow to meet the body needs. Incidence and prevalence of heart failure will continue to rise over the next several decades due to the baby boomers and medical advancements of surviving acute coronary syndrome. Pharmacotherapy management of heart failure heavily involves evidence based goal directed therapy, which helps lower 5 year mortality rate.

Tuesday, April 7, 2020

Pharmacology Conference

7:00 am - 8:00 am
PH-BR1: Influenza Treatment in the Primary Care Setting

By completing this session, participants will be able to apply new evidence into practice regarding the use of diagnostic testing, treatment and chemoprophylaxis for people with, or at risk for, influenza. Also, Incorporate the use of antiviral agents into practice based on their ability to reduce transmission, as well as treat people with influenza who are at normal or high risk for complications.

Content Developed by: John J. Russell, MD, Clinical Professor of Family and Community Medicine, Thomas Jefferson University Sidney Kimmel School of Medicine, Philadelphia, PA; Chair, Department of Family Medicine and Program Director, Family Medicine Residency, Abington – Jefferson Health, Abington, PA

This activity is supported by an educational grant from Genentech, Inc.
This continuing nurse education activity is provided by Vindico Medical Education.

8:15 am - 9:45 am
PH5: Infectious Disease Update

Although morbidity and mortality for infectious diseases during the last century has decreased, these diseases still cause a huge impact on the population in the US and in the world. In recent years some of the mortality rates from infectious diseases have actually risen for diseases such as HIV/AIDS, West Nile Virus and clostridium difficile. Worldwide the most infectious disease deaths each year are caused by three diseases: tuberculosis, malaria, and HIV/AIDS. These diseases cause over 300 million illnesses and more than 5 million deaths annually. Pneumonia and influenza account for 40% of infectious disease mortality in the U.S. Therefore it is critical to understand these diseases and those that are new and emerging.

10:00 am - 11:30 am
PH6: Geriatric Pharmacology/BEERS Criteria

Beer’s Criteria is a guideline that was developed by a panel of interdisciplinary geriatric and pharmacotherapy experts to help healthcare professionals to determine the safety of medications for older adults. The purpose of the project was to create a comprehensive, systematic review and grading of the evidence on drug-related problems and adverse drug reactions in older adults. The medications on the Beer’s list include those that have risks that outweigh benefits for individuals over the age of 65.

1:15 pm - 2:45 pm
PH7: Psychiatry Skills for Everyone: Treating Depression and Anxiety, No Matter Where You Work

This session will cover neurotransmitters that are targeted for treating depression and anxiety. Learn to recognize symptoms and severity of depression and anxiety disorders as listed in DSM IV and their influence on ADL. Also, get a better understanding of medication side effects, adverse events and the barriers for adherence for patients to achieve remission of their symptoms.

3:00 pm - 4:30 pm
PH8: Pharmacology for Sleep Disorders

Sleep disorders affect many people. This session will better prepare the learner by helping them identify healthy and normal sleep architecture across the lifespan along with the chemical neurotransmitters involved in sleep stagings. Session will review symptoms and neurotransmitters involved with insomnia, obstructive sleep apnea, restless leg syndrome, shift work sleep disorder and night terrors. Lastly, you will leave this session with a better understanding of medication interventions for all insomnia and sleep diagnosis.




General Attendee $800.00
Discounted Price
If Registered By


Monday, March 2, 2020

Senior (60+) /Student/New Grad $800.00
Discounted Price
If Registered By


Monday, March 2, 2020

Military $585.00


General Attendee $420.00
Discounted Price
If Registered By


Monday, March 2, 2020

Senior (60+)/Student/New Grad $420.00
Discounted Price
If Registered By


Monday, March 2, 2020

Military $295.00


General Attendee $420.00
Discounted Price
If Registered By


Monday, March 2, 2020

Senior (60+)/Student/New Grad $420.00
Discounted Price
If Registered By


Monday, March 2, 2020

Miltary $295.00
All registrations are subject to a $50 non-refundable administration fee



All registrations must be paid in full by credit card (Visa, MasterCard, American Express and Discover) at the time of registration. NPACE no longer accepts payment by check. 4th for Free, Letter of Credit and complimentary registrations all require a $50 non-refundable administration fee upon registration.

If using Letter of Credit, 4th for free, or complimentary registration, please contact NPACE 508-907-6424 x1 for registration information.


Written notice of cancellation must be received by email or letter.  A refund, excluding the $50 non-refundable administrative fee, will be issued when cancellation is received no later than one month prior to the conference start date. Refunds are processed based on the original form of payment.

A letter of credit, excluding the $50 non-refundable administrative fee, will be issued when cancellation is received between 30 and 8 days of the conference start date. This is valid for 12 months from issuance and may be used for towards any NPACE conference.

No refunds will be issued for cancellations received within 7 days of the conference start date.


In the very unlikely event that NPACE cancels or postpones a conference due to circumstances beyond its control, NPACE’s liability shall be limited to refund of paid registration fees.



Chicago Marriott Downtown Magnificent Mile

Image result for chicago marriott downtown magnificent mile

  540 North Michigan Avenue

  Chicago, IL 60611


Cut Off Date:                    March 12, 2020 (5:00 pm local time)

Discounted Rate:              $229 Single/Double (plus taxes)

Online Reservations:        CLICK HERE TO BOOK


Group rates can apply 3 days before and after the conference dates; based on availability


Complimentary use of fitness center.
Discounted Self-Parking at ROW Parking Garage across from hotel.
Complimentary Guest Room basic Internet Service for all Marriott Reward Members, can sign up at hotel otherwise discounted guest room basic internet for overnight guests at $1.00 per room per night.

NPACE Room Block Note

NPACE strongly advises that you do not make travel reservations until you have a confirmed conference registration. NPACE conferences frequently sell out prior to early registration date.

Hotel Rates are based on room block availability and can’t be guaranteed if room block sells out before cut off dates. Space and room types are limited, so please make your reservations early! Hotel cancellation policies vary, check with hotel for cancellation policy if you need to cancel your reservation. Only reservations made through the group block are eligible for additional amenities and discounts.

Downtown Chicago Hotel
Downtown Chicago Hotel Room

Abstract Submission

NPACE is currently accepting poster abstracts for our 2020 conference in Chicago. Research should be focused on health policy, innovation, evidence based clinical practice, scientific research, or collaboration and interdisciplinary practice. Sub-topic ideas should include primary care, mental health, pediatrics, geriatrics, or palliative- end of life care. Submission is open to students and faculty from MSN, DNP, and PhD programs.

Simply complete the Abstract Submission Form below to submit your abstract for review.


September 1, 2019 Online submission of abstracts opens
February 7, 2020 Online submission of abstracts close
February 15, 2020 Email notification sent to all submissions
February 24, 2020 Deadline to return completed Presenter Agreement
February 28, 2020 Deadline to register for conference



  1. Full name of submitting/corresponding author and all co-authors
  2. Abstract text:
    1. Use Times New Roman, 12 Font, 1-inch margins
    2. Limit to 300 words excluding title, authors info (affiliations) and references
  3. Highlight the main points
    1. Introduction: Info statement with purpose of the presentation
    2. Methods: Brief description of the research-background
    3. Discussion: Summary of the unpublished data or other relevant info
    4. Conclusion: Summarize in 1 or 2 sentences the primary outcomes of the study, including their potential significance
  4. Funding sources:  Funding sources (organizations, institutions, agencies) for the research included in the abstract should be listed.
  5. Must not contain any commercial bias


  • Resume(s) for author(s)
  • Short bio statements for all poster authors
  • One measurable learning outcome.
  • 50-word presentation summary that will be used for conference publication
  • Entire poster must fit onto a 3-foot x 4-foot board
  • Co-authors submitted with the accepted abstracts will be included in the conference materials.
  • Decisions on abstract acceptance are final.


Accepted abstracts must have a presenter in attendance during conference session breaks on Saturday, April 4, 2020 to present their poster(s).

It is not mandatory that the first author be pre-registered and present; the presenter may be any of the contributing authors or a colleague.


Author associated with an abstract must register for the conference and are responsible for all travel expenses (airfare, hotel, etc.) associated with presenting at the meeting. The conference registration is separate from the abstract submission. Abstracts will be removed from the conference if author(s) are not registered for the conference by 2/28/2020. If a presenter(s) withdraws from the conference the poster submission will be removed.

Note our Faculty Program: We recognize the important role of academic faculty in preparing the next generation of NP leaders, and as a show of support, we offer one free conference registration per 24-month period to full-time faculty of NP academic programs. A limited number of seats are put aside at each conference for faculty taking advantage of this NPACE Perk.


All abstracts will be reviewed and selected based on criteria requirements by an NPACE nurse planner. This will ensure adherence to ANCC Commission on Accreditation CE provider guidelines.


Upon acceptance of an abstract, presenters will receive a presenter agreement with dates and guidelines. This agreement will need to be signed and returned to NPACE within one week of receipt of email notification of poster acceptance. Failure to return agreement will result in removal of the abstract from the presentation.


Virtual Conference
Webinar (NPACE)
Webinar (Sponsored-Free)
In-person Conference
No thanks, just take me to the Exhibit Hall.